| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 137.34M | 142.79M | 130.79M | 81.69M | 58.54M | 54.98M |
| Gross Profit | 95.71M | 97.45M | 70.64M | 67.90M | 51.31M | 43.48M |
| EBITDA | 58.40M | 61.41M | 38.52M | 40.66M | 31.95M | 26.98M |
| Net Income | 43.39M | 45.70M | 28.27M | 29.64M | 23.16M | 19.27M |
Balance Sheet | ||||||
| Total Assets | 1.89B | 1.74B | 1.77B | 1.58B | 1.35B | 1.02B |
| Cash, Cash Equivalents and Short-Term Investments | 296.63M | 273.14M | 338.41M | 287.75M | 283.40M | 170.31M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.65B | 1.53B | 1.60B | 1.44B | 1.22B | 909.35M |
| Stockholders Equity | 241.74M | 213.21M | 170.33M | 144.10M | 127.41M | 107.32M |
Cash Flow | ||||||
| Free Cash Flow | 45.21M | 50.85M | 46.29M | 39.42M | 29.53M | 24.80M |
| Operating Cash Flow | 50.17M | 55.05M | 49.13M | 39.71M | 30.13M | 25.23M |
| Investing Cash Flow | -98.27M | 80.16M | -130.86M | -342.77M | -43.49M | -119.61M |
| Financing Cash Flow | 103.14M | -82.05M | 153.66M | 207.32M | 64.31M | 131.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $494.45M | 12.00 | 12.03% | 0.73% | 7.81% | 26.91% | |
76 Outperform | $462.16M | 9.06 | 15.02% | 2.08% | 8.21% | 29.65% | |
75 Outperform | $403.57M | 9.44 | 19.46% | 2.40% | -6.72% | 19.64% | |
75 Outperform | $448.59M | 14.99 | 7.71% | ― | 6.62% | 117.46% | |
75 Outperform | $472.19M | 10.53 | 10.86% | 1.92% | 6.25% | 24.92% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $430.58M | 20.64 | 6.16% | 3.69% | 50.36% | -56.64% |
On October 15, 2025, Bank7 Corp. announced its financial results for the third quarter ending September 30, 2025. The company reported a slight decrease in net income and earnings per share compared to the previous quarter, but saw an increase in total assets and loans. Despite these mixed results, Bank7 maintains robust capital levels, significantly above the minimum required for well-capitalized status, indicating strong financial health and potential for future growth.
The most recent analyst rating on (BSVN) stock is a Buy with a $52.00 price target. To see the full list of analyst forecasts on Bank7 stock, see the BSVN Stock Forecast page.